enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension [Enrosite Silver]
- RxCUI
- 2704946
- RxNorm name
- enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension [Enrosite Silver]
- Display name
- enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension [Enrosite Silver]
- Full name
- enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension [Enrosite Silver]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3413666f-7083-4cf7-a633-5aa1f79d7de3 | Enrosite Silver 0.5 % / 1 % Otic Suspension [PSN] · enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension [Enrosite Silver] [SBD] · Enrosite Silver (enrofloxacin 0.5 % / silver sulfadiazine 1 % ) Otic Suspension [SY] | 3 | 1 | VET one ® Enrosite™ Silver Otic (enrofloxacin/silver sulfadiazine) Antibacterial-Antimycotic Emulsion | 20250207 |